Federal Funding Opportunities, December 12, 2021-January 24, 2022

National Science Foundation Mid-Career Advancement Application deadline: February 7, 2022 National Institutes of Health Risk and Protective Factors of Family Health and Family Level Interventions (R01 – Clinical Trial Optional) (PAR-21-358) National Institute on Minority Health and Health Disparities National Cancer Institute National Institute of Nursing Research Office of Behavioral and Social Sciences Research Office of Disease Prevention Office of Research on Women’s Health Application Receipt Date(s): Multiple dates, see announcement. HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed) (RFA-DA-22-044) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Dental and Craniofacial Research Application Receipt Date(s): March 10, 2022 HEAL Initiative: Exploratory Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R21- Clinical Trial Not Allowed) (RFA-DA-22-045) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Dental and Craniofacial Research Application Receipt Date(s): March 10, 2022 Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) (PAS-22-096) National Institute of Diabetes and Digestive and Kidney Diseases National Heart, Lung, and Blood Institute National Institute on Aging Application Receipt Date(s): January 07, 2025 Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed) (RFA-AG-23-003) National Institute on Aging Application Receipt Date(s): March 03, 2022 HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional) (RFA-DA-22-034) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional) (RFA-DA-22-042) National Institute on Drug Abuse National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional) (RFA-DA-22-043) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional) (RFA-DA-22-046) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 HEAL Initiative: Understanding Polysubstance Use and Improving Service Delivery to Address Polysubstance Use (R01 Clinical Trial Optional) (RFA-DA-22-047) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 HEAL Initiative: Pilot and Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional) (RFA-DA-22-048) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Application Receipt Date(s): March 10, 2022 HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required) (RFA-NS-22-037) National Institute of Neurological Disorders and Stroke National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute on Minority Health and Health Disparities National Institute of Nursing Research Office of Research on Women’s Health Application Receipt Date(s): March 22, 2022 Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 Clinical Trial Optional) (RFA-MD-22-007) National Institute on Minority Health and Health Disparities National Institute of Mental Health Office of Disease Prevention Application Receipt Date(s): March 28, 2022 Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) (RFA-MD-22-003) National Institute on Minority Health and Health Disparities National Center for Advancing Translational Sciences Application Receipt Date(s): April 04, 2022 Innovations for Healthy Living – Improving Minority Health and Eliminating Health Disparities (R43/R44 – Clinical Trial Optional) (RFA-MD-22-004) National Institute on Minority Health and Health Disparities National Center for Advancing Translational Sciences National Heart, Lung, and Blood Institute National Institute on Aging National Institute of Biomedical Imaging and Bioengineering National Institute on Drug Abuse National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Mental Health Application Receipt Date(s): April 04, 2022 Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional) (RFA-HD-22-024) Eunice Kennedy Shriver National Institute of Child Health and Human Development Office of Research on Women’s Health Application Receipt Date(s): April 18, 2022 Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) (RFA-MH-22-170) National Institute of Mental Health National Institute on Drug Abuse Office of Behavioral and Social Sciences Research Application Receipt Date(s): May 10, 2022 Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) (RFA-MH-22-171) National Institute of Mental Health National Institute on Drug Abuse Office of Behavioral and Social Sciences Research Application Receipt Date(s): May 10, 2022 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) (RFA-TR-22-013) National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Neurological Disorders and Stroke Application Receipt Date(s): May 22, 2023 Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional) (RFA-ES-22-002) National Institute of Environmental Health Sciences Application Receipt Date(s): June 09, 2022 Lipids in Brain Aging and Alzheimer’s Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) (RFA-AG-23-009) National Institute on Aging Application Receipt Date(s): June 14, 2022 Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) (RFA-MH-22-135) National Institute of Mental Health National Institute on Aging Application Receipt Date(s): October 15, 2022 Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) (RFA-MH-22-136) National Institute of Mental Health National Institute on Aging Application Receipt Date(s): October 15, 2022 Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) (PAR-22-057) National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Office of Research on Women’s Health Application Receipt Date(s): May 01, 2023 Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed) (RFA-HG-22-004) National Human Genome Research Institute Application Receipt Date(s): July 01, 2023 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional) (PAR-22-093) National Institute on Aging National Institute of Neurological Disorders and Stroke Application Receipt Date(s): November 12, 2024 Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R21 Clinical Trial Optional) (PAR-22-094) National Institute on Aging Application Receipt Date(s): November 12, 2024 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) (PAR-22-060) National Institute of Dental and Craniofacial Research National Center for Complementary and Integrative Health National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): January 07, 2025 HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) (RFA-NS-22-034) National Institute of Neurological Disorders and Stroke National Center for Advancing Translational Sciences National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): Multiple dates, see announcement. Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) (PAR-21-357) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Cancer Institute National Eye Institute National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Application Receipt Date(s): Multiple dates, see announcement. Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (PAR-21-359) National Institute on Aging Application Receipt Date(s): Multiple dates, see announcement. Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (PAR-21-360) National Institute on Aging Application Receipt Date(s): Multiple dates, see announcement. Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 – Clinical Trials Optional) (PAR-22-092) National Institute on Minority Health and Health Disparities National Cancer Institute National Eye Institute National Institute on Aging National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Nursing Research Office of Research on Women’s Health Application Receipt Date(s): Multiple dates, see announcement.